Skip to content

A multicenter study of comparing effects of thulium laser en bloc resection and electrical transurethral resection of the non-muscle invasive bladder cancer

A multicenter study of comparing effects of thulium laser en bloc resection and electrical transurethral resection of the non-muscle invasive bladder cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009513
Enrollment
Unknown
Registered
2016-10-20
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

Test group:Transurethral resection of bladder tumor with thulium laser

Sponsors

Department of Urology Center, Shanghai General Hospital, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Pathological or histological diagnosis of primary non-muscle invasive bladder urothelial carcinoma (TaTisT1); 2. Imaging examinations showed the bladder muscle has not been affected, no lymph node metastasis or distant metastasis; 3. Patients who agree to TURBT surgery, and will be effected to the postoperative follow-up treatment such as conventional infusion after the operation; 4. Function of main organs (heart, liver, lung, kidney) should be normal, PS score 0-2; 5. Bladder capacity= 200ml.

Exclusion criteria

Exclusion criteria: 1. Find distant metastasis ,infiltration of the surrounding organs or relapse before operation.Metastatic bladder cancer or other cancers involve the bladder; 2. Received chemotherapy or BCG perfusion therapy in the nearly 3 months; 3. Patients who can not tolerate the serious side effects during the bladder perfusion treatment process (bladder irritation and other symptoms); 4. Patients during pregnancy ,critical care patients and patients who have other cases of surgical contraindications.Such as serious cardiovascular disease,coagulation abnormalities,non-transitional epithelial tumors( such as adenocarcinoma and squamous cell carcinoma),acute cystitis,can not be supine because of spinal deformity,untreated urethral stricture.

Design outcomes

Primary

MeasureTime frame
The residual rate of tumor in the second operation of the two surgical methods;

Secondary

MeasureTime frame
Perioperative complications associated with two surgical methods;1 year, 2 years, 3 years of tumor recurrence rate and progression rate;5-year recurrence-free survival rate and progression-free survival rate;The length of operation, catheter retention and hospitalization;

Countries

China

Contacts

Public ContactLiu Haitao

Department of Urology Center, Shanghai General Hospital, Shanghai Jiaotong University

doctorlht69@163.com+86 15301655608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026